Floatz logo

Hyaluronidase

Lumbar Radiculopathy

EPC Education s.r.o.protein_peptideN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Lumbar Radiculopathy cohort.

Asset / SponsorPhaseRating
Pentoxifylline
St Joseph University, Beirut, Lebanon
Phase 4BB
Triamcinalone
University of Miami
Phase 4BB
IBUPROFEN
St Joseph University, Beirut, Lebanon
Phase 4BB
DEXAMETHASONE
University of Miami
Phase 4BB
Naltrexone
Allodynic Therapeutics, Inc
Phase 2B
sx600
SpineThera Australia PTY LTD
Phase 1/2CCC
Marijuana
University of California, San Diego
Early Phase 1C

Same molecule, other indications

Hyaluronidase is also rated in:

T-cell acute lymphoblastic leukemiaDormant
CCC
Indicative ·
53 / 100
View asset →
Muscle SpasticityDormant
CCC
Indicative ·
53 / 100
View asset →
diffuse large B-cell lymphomaDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →